Difference between revisions of "Prednisolone (Millipred)"
Jump to navigation
Jump to search
Warner-admin (talk | contribs) m (Text replacement - "[[Category:Hodgkin lymphoma " to "[[Category:Classical Hodgkin lymphoma ") |
Warner-admin (talk | contribs) m (Text replacement - "[http://www.utdol.com/online/content/search.do UpToDate (courtesy of Lexicomp)], or" to "or") |
||
| (12 intermediate revisions by 2 users not shown) | |||
| Line 6: | Line 6: | ||
*[[Steroid conversions]] | *[[Steroid conversions]] | ||
| − | For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias such as | + | For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias such as Micromedex, Lexicomp, or the prescribing information.<ref name="insert"></ref> |
==Diseases for which it is used== | ==Diseases for which it is used== | ||
| − | *[[Acquired | + | *[[Acquired hemophilia A]] |
*[[B-cell acute lymphoblastic leukemia]] | *[[B-cell acute lymphoblastic leukemia]] | ||
*[[Breast cancer]] | *[[Breast cancer]] | ||
| Line 17: | Line 17: | ||
*[[Extranodal NK- and T-cell lymphoma, nasal type]] | *[[Extranodal NK- and T-cell lymphoma, nasal type]] | ||
*[[Follicular lymphoma]] | *[[Follicular lymphoma]] | ||
| − | *[[Hodgkin lymphoma]] | + | *[[Classical Hodgkin lymphoma]] |
*[[Langerhans cell histiocytosis]] | *[[Langerhans cell histiocytosis]] | ||
*[[Mantle cell lymphoma]] | *[[Mantle cell lymphoma]] | ||
| Line 23: | Line 23: | ||
*[[Multiple myeloma]] | *[[Multiple myeloma]] | ||
*[[Prostate cancer]] | *[[Prostate cancer]] | ||
| + | *[[Warm autoimmune hemolytic anemia]] | ||
==Diseases for which it was used== | ==Diseases for which it was used== | ||
| Line 28: | Line 29: | ||
==Patient drug information== | ==Patient drug information== | ||
| − | *[https://chemocare.com/ | + | *[https://chemocare.com/druginfo/prednisolone Prednisolone (Millipred) patient drug information (Chemocare)]<ref>[https://chemocare.com/druginfo/prednisolone Prednisolone (Millipred) patient drug information (Chemocare)]</ref> |
*[http://www.uptodate.com/contents/prednisolone-patient-drug-information Prednisolone (Millipred) patient drug information (UpToDate)]<ref>[http://www.uptodate.com/contents/prednisolone-patient-drug-information Prednisolone (Millipred) patient drug information (UpToDate)]</ref> | *[http://www.uptodate.com/contents/prednisolone-patient-drug-information Prednisolone (Millipred) patient drug information (UpToDate)]<ref>[http://www.uptodate.com/contents/prednisolone-patient-drug-information Prednisolone (Millipred) patient drug information (UpToDate)]</ref> | ||
| + | |||
| + | ==History of changes in EMA indication== | ||
| + | *1956-07-13: EURD | ||
| + | ==History of changes in PMDA indication== | ||
| + | *2011-09-16: New indication for the treatment of [[multiple myeloma]]. | ||
| + | *2015-06-26: revised indications and a new dosage for the treatment of [[:Category:Lymphomas|malignant lymphoma]] and similar diseases (closely-related diseases). | ||
==Also known as== | ==Also known as== | ||
*'''Generic names:''' delta(1)hydrocortisone, delta1-dehydro-hydrocortisone, deltahydrocortisone, metacortandralone, prednisolone acetate, prednisolone tebutate | *'''Generic names:''' delta(1)hydrocortisone, delta1-dehydro-hydrocortisone, deltahydrocortisone, metacortandralone, prednisolone acetate, prednisolone tebutate | ||
| − | *'''Brand names:''' Adnisolone, Aprednislon, Capsoid, Cortalone, Cortisolone, Cotolone, Dacortin H, Decaprednil, Decortin H, Delta-Cortef, Deltacortril, Delta-Diona, Delta-Phoricol, Deltasolone, Deltidrosol, Dhasolone, Di-Adreson-F, Dontisolon D, Estilsona, Fisopred, Frisolona, Gupisone, Hostacortin H, Hydeltra, Hydeltrasol, Klismacort, Kuhlprednon, Lenisolone, Lepi-Cortinolo, Linola-H N, Linola-H-Fett N, Longiprednil, Medicort, Meticortelone, Meti-derm, Millipred, Opredsone, Orapred, Panafcortelone, Predcor, Predicort, Precortisyl, Pred-Clysma, Predeltilone, Predni-Coelin, Prednicortelone, Predni-Helvacort, Prelone, Prenilone, Pri-Cortin, Veripred | + | *'''Brand names:''' Adnisolone, Aprednislon, Capsoid, Cortalone, Cortisolone, Cotolone, Dacortin H, Decaprednil, Decortin H, Delta-Cortef, Deltacortril, Delta-Diona, Delta-Phoricol, Deltasolone, Deltidrosol, Dhasolone, Di-Adreson-F, Dontisolon D, Estilsona, Fisopred, Frisolona, Gupisone, Hostacortin H, Hydeltra, Hydeltrasol, Klismacort, Kuhlprednon, Lenisolone, Lepi-Cortinolo, Linola-H N, Linola-H-Fett N, Longiprednil, Medicort, Meticortelone, Meti-derm, Millipred, Opredsone, Orapred, Panafcortelone, Predcor, Predicort, Precortisyl, Pred-Clysma, Predeltilone, Predni-Coelin, Prednicortelone, Predni-Helvacort, Predonine, Prelone, Prenilone, Pri-Cortin, Veripred |
==References== | ==References== | ||
| Line 44: | Line 51: | ||
[[Category:Chronic lymphocytic leukemia medications]] | [[Category:Chronic lymphocytic leukemia medications]] | ||
| − | [[Category:Acquired | + | [[Category:Acquired hemophilia A medications]] |
[[Category:B-cell acute lymphoblastic leukemia medications]] | [[Category:B-cell acute lymphoblastic leukemia medications]] | ||
[[Category:Breast cancer medications]] | [[Category:Breast cancer medications]] | ||
| Line 57: | Line 64: | ||
[[Category:Multiple myeloma medications]] | [[Category:Multiple myeloma medications]] | ||
[[Category:Prostate cancer medications]] | [[Category:Prostate cancer medications]] | ||
| + | [[Category:Warm autoimmune hemolytic anemia medications]] | ||
[[Category:Acute myeloid leukemia medications (historic)]] | [[Category:Acute myeloid leukemia medications (historic)]] | ||
[[Category:FDA approved in 1955]] | [[Category:FDA approved in 1955]] | ||
| + | [[Category:EMA approved in 1956]] | ||
[[Category:PMDA approved drugs]] | [[Category:PMDA approved drugs]] | ||
[[Category:WHO Essential Cancer Medicine]] | [[Category:WHO Essential Cancer Medicine]] | ||
Latest revision as of 00:14, 6 July 2024
General information
Class/mechanism: Corticosteroid, glucocorticoid.[1][2][3]
Route: PO, gtt (ophthalmic eye drops)
Extravasation: n/a
For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias such as Micromedex, Lexicomp, or the prescribing information.[1]
Diseases for which it is used
- Acquired hemophilia A
- B-cell acute lymphoblastic leukemia
- Breast cancer
- Burkitt lymphoma
- Chronic lymphocytic leukemia
- Diffuse large B-cell lymphoma
- Extranodal NK- and T-cell lymphoma, nasal type
- Follicular lymphoma
- Classical Hodgkin lymphoma
- Langerhans cell histiocytosis
- Mantle cell lymphoma
- Marginal zone lymphoma
- Multiple myeloma
- Prostate cancer
- Warm autoimmune hemolytic anemia
Diseases for which it was used
Patient drug information
- Prednisolone (Millipred) patient drug information (Chemocare)[4]
- Prednisolone (Millipred) patient drug information (UpToDate)[5]
History of changes in EMA indication
- 1956-07-13: EURD
History of changes in PMDA indication
- 2011-09-16: New indication for the treatment of multiple myeloma.
- 2015-06-26: revised indications and a new dosage for the treatment of malignant lymphoma and similar diseases (closely-related diseases).
Also known as
- Generic names: delta(1)hydrocortisone, delta1-dehydro-hydrocortisone, deltahydrocortisone, metacortandralone, prednisolone acetate, prednisolone tebutate
- Brand names: Adnisolone, Aprednislon, Capsoid, Cortalone, Cortisolone, Cotolone, Dacortin H, Decaprednil, Decortin H, Delta-Cortef, Deltacortril, Delta-Diona, Delta-Phoricol, Deltasolone, Deltidrosol, Dhasolone, Di-Adreson-F, Dontisolon D, Estilsona, Fisopred, Frisolona, Gupisone, Hostacortin H, Hydeltra, Hydeltrasol, Klismacort, Kuhlprednon, Lenisolone, Lepi-Cortinolo, Linola-H N, Linola-H-Fett N, Longiprednil, Medicort, Meticortelone, Meti-derm, Millipred, Opredsone, Orapred, Panafcortelone, Predcor, Predicort, Precortisyl, Pred-Clysma, Predeltilone, Predni-Coelin, Prednicortelone, Predni-Helvacort, Predonine, Prelone, Prenilone, Pri-Cortin, Veripred
References
Categories:
- Drugs
- Oral medications
- Steroids
- Immunosuppressants
- Chronic lymphocytic leukemia medications
- Acquired hemophilia A medications
- B-cell acute lymphoblastic leukemia medications
- Breast cancer medications
- Burkitt lymphoma medications
- Diffuse large B-cell lymphoma medications
- Extranodal NK- and T-cell lymphoma, nasal type medications
- Follicular lymphoma medications
- Classical Hodgkin lymphoma medications
- Langerhans cell histiocytosis medications
- Mantle cell lymphoma medications
- Marginal zone lymphoma medications
- Multiple myeloma medications
- Prostate cancer medications
- Warm autoimmune hemolytic anemia medications
- Acute myeloid leukemia medications (historic)
- FDA approved in 1955
- EMA approved in 1956
- PMDA approved drugs
- WHO Essential Cancer Medicine